The Editorial Board of the journal is responsible for maintaining the quality and integrity of the journal's content. The board members are experts in their respective fields and play a crucial role in the peer review process, ensuring that all articles published meet the highest academic standards.
The Editorial Board is committed to upholding the principles of academic excellence, transparency, and ethical publishing practices. They work closely with authors, reviewers, and the editorial team to facilitate a smooth publication process.
Department: Department of Drug Discovery and Clinical Research
Affiliation: Dikernis General Hospital, Dikernis
Designation: Senior Pharmacist
Email: amgad_rabie@hms.harvard.eduCountry: Egypt
Dr. Amgad Mohammed Rabie Hamed Fouda has completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers and scientists. His new researches focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published more than 25 papers in very reputed journals and serving as an Editorial Board Member of great repute.
Affiliation: University of Wisconsin, Madison
Department: Department of Pharmacy
Designation: Staff Scientist
Email: nmamidi@wisc.eduCountry: United States
Dr. Narsimha Mamidi is a Staff Scientist at the School of Pharmacy, University of Wisconsin-Madison, with extensive expertise in nanomedicine, drug delivery, biomaterials, and translational cancer research. He earned his Ph.D. in Chemical Sciences from IIT Guwahati, India, where he received the Eli Lilly Outstanding Thesis Award. His interdisciplinary research focuses on the development of peptide-conjugated lipid nanoparticles, engineered hydrogels, and nanocomposites for targeted drug and gene delivery, with applications in cancer immunotherapy, pulmonary diseases, and regenerative medicine. Dr. Mamidi has held academic positions in India, Mexico, and the USA, and has mentored numerous students across doctoral, master's, and undergraduate levels. He has authored over 45 peer-reviewed publications in high-impact journals such as Nature Biotechnology, Advanced Healthcare Materials, Nanoscale, and Nano Today, and has been recognized with several awards, including the 2022 Outstanding Reviewer Award from Polymers. His technical skill set spans synthetic organic chemistry, peptide synthesis, nanoparticle engineering, CRISPR-based EV analysis, and a range of analytical and imaging techniques. Passionate about bridging lab-scale innovations with clinical applications, he actively contributes to research, teaching, and academic outreach across global platforms.
Affiliation: Universiti Sains Malaysia, Pulau Pinang
Department: Department of Pharmaceutical Science
Designation: Associate Professor
Email: sychan@usm.myCountry: Malaysia
Affiliation: Integral University, Lucknow
Department: Department of Pharmacy
Designation: Professor
Email: shazia@iul.ac.inCountry: India
Dr. Shazia Usmani is an accomplished academic and researcher with expertise in pharmaceutical sciences. She has extensive teaching and research experience, focusing on drug design, medicinal chemistry, and pharmacology. Dr. Usmani has contributed to numerous publications in peer-reviewed journals and actively participates in academic collaborations and scientific events. She is dedicated to advancing research and education in her field and brings strong leadership and editorial skills to her professional roles.
Affiliation: University of Samarra, Samarra
Department: Department of Applied Chemistry
Designation: Lecturer
Email: yasmin@uosamarra.edu.iqCountry: Iraq
Dr. Yasameen Hmeed Jasim Al-Daraji is a Lecturer in Biochemistry at the University of Samarra, Iraq, with over a decade of academic and research experience. She holds an M.Sc. in Biochemistry and is currently pursuing her Ph.D. in Clinical Chemistry at Erciyes University, Turkey, focusing on molecular markers in brain cancer. Her research spans clinical biochemistry, metabolic disorders, and the therapeutic effects of natural compounds. She has published several peer-reviewed studies on topics such as the impact of plant-derived flavonoids on diabetic and liver disease models, UVC radiation effects, and microbial nutrient media production. Her work appears in journals like the International Journal of Science & Technology, Tikrit Journal of Pure Sciences, and Karbala Journal of Pharmaceutical Sciences. Dr. Al-Daraji has also contributed to curriculum development, scientific committees, and quality assurance initiatives within her institution. She is fluent in English and Turkish, with international certifications and active participation in scientific conferences.